Cellgram-DC

TERMINATED · PHASE1 · Ovarian Cancer, Advanced Epithelial Ovarian Cancer, Recurrent Epithelial Cancer of Ovary

Difficulties in patient recruitment.

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.